Editor-in-Chief: Daniel Scherman
Median time to first editorial decision: 7 days

Rare Disease and Orphan Drugs Journal

Journal sees increased submissions, broader international authorship, and anticipates first Impact Factor in 2026
Rare Disease and Orphan Drugs Journal (RDODJ) has been officially indexed in the Emerging Sources Citation Index (ESCI) of Web of Science as of September 16, 2025!
Fifteen Editorial Board Members of RDODJ Named among 2025 World's Top 2% of Scientists!
Starting from 2022, all publications of RDODJ will be fully indexed in Scopus.
Familial Hypercholesterolemia

Coming soon.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/